Teva Pharmaceutical Industries Limited, headquartered in Israel, develops, manufactures and markets generic and innovative human pharmaceuticals and active pharmaceutical ingredients.
The NASDAQ-100 Index, launched in January 1985, is one of the most widely followed benchmarks in the world. The NASDAQ -100 Index Tracking Stock represents ownership in the NASDAQ -100 Trust. The Trust holds a portfolio of equity securities that compose the NASDAQ -100 Index and aims to provide investment results that generally correspond with its performance.
NASDAQ (OTCBB:NDAQ) is the world's largest electronic stock market. With approximately 3,800 companies, NASDAQ lists more companies and trades more shares per day than any other U.S. market. Over the past five years, NASDAQ has outpaced all other U.S. markets in listing IPOs. It is home to category-defining companies that are leaders across all areas of business including technology, retail, communications, financial services, media and biotechnology industries. NASDAQ is a key driver of capital formation. For more information about NASDAQ, visit the NASDAQ Web site at www.NASDAQ.com or the NASDAQ NewsroomSM at www.NASDAQNews.com.
The Trustee for the Nasdaq-100 Trust is required to adjust the composition of the Trust within 3 business days of the effective date of a change to the composition of the Nasdaq-100 Index.
Investment returns and principal value will fluctuate so that an investor's shares, when redeemed or sold, may be worth more or less than the original cost.
For more complete information about Nasdaq-100 Index Tracking StockSM, including trust performance charges, expenses and potential risks, obtain a prospectus from your broker, or call (800) 843-2639 or visit our web site at www.nasdaq-100.com. Read it carefully before you invest.
